Auris Stock Today

Auris Medical Holding is currently unavailable and cannot be used in your analysis. The information on this page reflects the last day Auris Medical was actively traded.
Valuation
Check how we calculate scores

Auris Medical Stock Profile

Auris Medical Holding Ltd., a clinical-stage biopharmaceutical company, developing therapeutics that address important unmet medical needs in neurotology, rhinology and allergy, and CNS disorders. Auris Medical Holding Ltd. was founded in 1998 and is headquartered in Hamilton, Bermuda. Auris Medical operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 8 people. more on Auris Medical
Auris Medical is now traded under the symbol CYTO. Please update your portfolios or report it if you believe this is an error. Report It!
Legal NameAuris Medical Holding
New SymbolCYTO
ChairmanJames Healy  (View All)
Average Analyst Recommendation
Analysts covering Auris Medical report their recommendations after researching Auris Medical's financial statements, talking to executives and customers, or listening in on Auris Medical's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Auris Medical Holding. The Auris consensus assessment is calculated by taking the average forecast from all of the analysts covering Auris Medical.
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of Auris Medical's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Not RatedUndervalued
Auris Medical Holding (EARS) is traded on NCM Exchange in USA and employs 8 people. The company currently falls under 'Micro-Cap' category with current market capitalization of 39.19 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Auris Medical's market, we take the total number of its shares issued and multiply it by Auris Medical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. Auris Medical Holding conducts business under Healthcare sector and is part of Biotechnology industry. The entity has 12.87 M outstanding shares of which 362.97 K shares are currently shorted by private and institutional investors with about 0.15 trading days to cover. Auris Medical Holding currently holds about 11.26 M in cash with (4.84 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.88.
Check Auris Medical Probability Of Bankruptcy

Auris Stock Price Odds Analysis

What are Auris Medical's target price odds to finish over the current price? In regard to a normal probability distribution, the odds of Auris Medical jumping above the current price in 90 days from now is about 90.63%. The Auris Medical Holding probability density function shows the probability of Auris Medical stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days Auris Medical has a beta of 0.0336 suggesting as returns on the market go up, Auris Medical average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Auris Medical Holding will be expected to be much smaller as well. Additionally, the company has an alpha of 0.1091, implying that it can generate a 0.11 percent excess return over DOW after adjusting for the inherited market risk (beta).
 Odds Down 3.05HorizonTargetOdds Up 3.05 
9.29%90 days
 3.05 
90.63%
Based on a normal probability distribution, the odds of Auris Medical to move above the current price in 90 days from now is about 90.63 (This Auris Medical Holding probability density function shows the probability of Auris Stock to fall within a particular range of prices over 90 days) .

Auris Medical Holding Risk Profiles

Investors will always prefer to have the highest possible return on investment while minimizing volatility. Auris Medical market risk premium is the additional return an investor will receive from holding Auris Medical long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Auris Medical. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Auris Medical's alpha and beta are two of the key measurements used to evaluate Auris Medical's performance over the market, the standard measures of volatility play an important role as well.

Auris Stock Against Markets

Picking the right benchmark for Auris Medical stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Auris Medical stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Auris Medical is critical whether you are bullish or bearish towards Auris Medical Holding at a given time.

Delisting Warning - EARS

Auris Medical Holding was delisted

  The entity Auris Medical Holding with a symbol EARS was delisted from NCM Exchange. Please use Altamira Therapeutics with a symbol CYTO from now on.

Auris Medical Corporate Directors

Auris Medical corporate directors refer to members of an Auris Medical board of directors. The board of directors generally takes responsibility for the Auris Medical's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Auris Medical's board members must vote for the resolution. The Auris Medical board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
Calvin Roberts - Non-Executive Independent DirectorProfile
Mats Blom - DirectorProfile
Antoine Papiernik - Non-Executive Independent DirectorProfile
Berndt Modig - Non-Executive Independent DirectorProfile
Continue to Investing Opportunities. Note that the Auris Medical Holding information on this page should be used as a complementary analysis to other Auris Medical's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.

Other Tools for Auris Stock

When running Auris Medical Holding price analysis, check to measure Auris Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Auris Medical is operating at the current time. Most of Auris Medical's value examination focuses on studying past and present price action to predict the probability of Auris Medical's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Auris Medical's price. Additionally, you may evaluate how the addition of Auris Medical to your portfolios can decrease your overall portfolio volatility.
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Go
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Go
Piotroski F Score
Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
Go
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Go
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Go
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Go
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Go